TFR2
Transferrin receptor protein 2
As of the edition of 20 October 2026, TFR2 (transferrin receptor protein 2, UniProt Q9UP52) has 1 drug tested at it and 1 company on the list, 0 on route A and 1 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q9UP52
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- At a membrane
- Disease areas
- Inherited and neonatal; Nervous system; Nutrition and metabolism; Skin and connective tissue
- Registered trials of its drugs
- 7
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Pabinafusp alfa | Marketed | Phase 3 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 1 |
| Total on the list | 1 |
| Company | Route |
|---|---|
| JCR Pharmaceuticals | Route B |
The other 0 companies at TFR2
In the product1 company in all; 0 are not named here, and no score is.
See the 1 companies at TFR2, ranked, with the facts behind eachRequest access. Nothing is shown until you do.